Differential (Click to cross reference) adverse drug reaction alpha-fetoprotein aminoglycoside amniocentesis ampicillin antiarrhythmic drugs antibiotics antibiotics, neurologic complications with anticholinergic drugs anticholinergic drugs, side effects of anticonvulsants anticonvulsants, blood level determination of anticonvulsants, compliance anticonvulsants, effectiveness anticonvulsants, selection of anticonvulsants, teratogenicity of anticonvulsants, untoward effects of artane beta adrenergic blocker breast feeding calcium antagonist chloroquine ciprofloxacin congenital birth defects congenital malformation contrast agents, neurotoxicity of counselling dilantin drug induced neurologic disorders drug interactions efficacy enzyme, induction erythromycin fluoroquinolones folic acid genetic counselling headache iatrogenic neurologic disorders interferon intracranial hypertension, benign levonorgestrel lithium myasthenia gravis myasthenia gravis, drug induced myasthenia gravis, unmasked myasthenic syndrome neuromuscular blockade nicotine obstetric neurologic injuries oral contraceptives patient information and support penicillamine practice guidelines pregnancy, anticonvulsants during pregnancy, neurologic complications in prenatal diagnosis by amniocentesis quinidine review article seizure seizure, pregnancy seizure, treatment of seizure, treatment of, monotherapy seizure, women steroid timolol treatment of neurologic disorder ultrasonography verapamil vitamin K vitamin supplementation

Showing articles 0 to 4 of 4 Treatment of Women with Epilepsy Seminars in Neurology 22:289-297, Pack.A.M.&Morrell,M.J., 2002 Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement) Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998 Drugs and Myasthenia Gravis, An Update Arch Int Med 157:399-408, Wittbrodt,E.T., 1997 Levonorgestrel Implants and Intracranial Hypertension NEJM 332:1720-1721, Alder,J.B.,et al, 1995 Showing articles 0 to 4 of 4